Perioperative Use of Tranexamic Acid in General Surgery
JAMA Surgery · 2026
DOI: 10.1001/jamasurg.2025.5498 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JAMA Surgery, 2026. Verfasst von Lucas Monteiro Delgado und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Minas Gerais, Belo Horizonte-MG, Brazil. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Blood Loss, Surgical, Perioperative Care, Surgical Procedures, Operative. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Tranexamic acid (TXA) is increasingly used to minimize perioperative bleeding. However, its efficacy and safety profile across general surgical procedures remains unclear.
Objective
To evaluate the efficacy and safety of prophylactic TXA in reducing intraoperative blood loss, need for transfusion, and major bleeding in general surgery, while assessing its association with thromboembolic events and mortality. Data Sources PubMed, Embase, and Cochrane Library were systematically searched from inception to April 3, 2025. Study Selection Randomized clinical trials (RCTs) comparing TXA to placebo in adult patients undergoing general surgery and reporting at least 1 predefined outcome of interest were included. Data Extraction and Synthesis Two reviewers independently extracted data and assessed risk of bias. Mean differences (MDs) and risk ratios (RRs) with 95% CIs were pooled using random-effects models. Heterogeneity was assessed using the I 2 statistic.
Results
Twenty-six RCTs with a total of 6976 patients were included. TXA use was associated with lower intraoperative blood loss (MD, −35.85 mL; 95% CI, −57.20 to −14.51 mL; I 2 = 91%; P = .001), reduced need for transfusion (RR, 0.75; 95% CI, 0.60-0.94; I 2 = 54%; P = .01), and fewer major bleeding events (RR, 0.72; 95% CI, 0.59-0.89; I 2 = 0%; P = .002). No significant differences were found in venous thromboembolism (RR, 1.09; 95% CI, 0.62-1.92; I 2 = 15%; P = .75), mortality (RR, 1.08; 95% CI, 0.72-1.61; I 2 = 0%; P = .71), and length of stay (MD, −0.54 days; 95% CI, −1.15 to 0.06 days; I 2 = 73%; P = .08). In the subgroup analysis restricted to abdominal procedures, the benefits observed in the overall population on intraoperative blood loss and need for transfusion were no longer present. In the hepatobiliary subgroup, TXA was associated with a significant reduction in major bleeding (RR, 0.59; 95% CI, 0.39-0.90; I 2 = 0%; P = .01), while no significant differences were observed for the other outcomes. Conclusions and Relevance This systematic review and meta-analysis found that prophylactic TXA use was associated with lower intraoperative blood loss, transfusion requirements, and major bleeding without an observed increase in thromboembolic or mortality risk. Although these findings support the use of TXA in general surgery procedures, the decision to use TXA should be individualized considering individual patient characteristics and the specific procedure being performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Universidade Federal de Minas Gerais, Belo Horizonte-MG, Brazil.
- Department of Colorectal Surgery, Heliópolis Hospital, São Paulo-SP, Brazil.
- Universidade Municipal de São Caetano do Sul (USCS), São Paulo-SP, Brazil.
- Universidade Federal de Santa Catarina, Florianópolis-SC, Brazil.
- AC Camargo Cancer Center, São Paulo-SP, Brazil.
- Universidade Federal do Espírito Santo, Vitória-ES, Brazil.
Zitieren
APA
Delgado, L. M., Pompeu, B. F., Martins, G. H. A., Azevedo, M. L., Pasqualotto, E., Chulam, T. C., & de Figueiredo, S. M. P. (2026). Perioperative Use of Tranexamic Acid in General Surgery. JAMA Surgery. https://doi.org/10.1001/jamasurg.2025.5498
Vancouver
Delgado LM, Pompeu BF, Martins GHA, Azevedo ML, Pasqualotto E, Chulam TC, et al. Perioperative Use of Tranexamic Acid in General Surgery. JAMA Surgery. 2026. doi:10.1001/jamasurg.2025.5498
BibTeX
@article{Delgado2026,
author = {Delgado, Lucas Monteiro and Pompeu, Bernardo Fontel and Martins, Gabriel Henrique Acedo and Azevedo, Mariana Lima and Pasqualotto, Eric and Chulam, Thiago Celestino and de Figueiredo, Sérgio Mazzola Poli},
title = {Perioperative Use of Tranexamic Acid in General Surgery},
journal = {JAMA Surgery},
year = {2026},
doi = {10.1001/jamasurg.2025.5498}
}
EUVIMED